News

Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Regulatory news - March 2020Regulatory news - March 2020February news: Upskilling the UK cell and gene therapy industryFebruary news: Upskilling the UK cell and gene therapy industryCGT Catapult launch new online cell confluency tool to improve consistency in cell cultureCGT Catapult launch new online cell confluency tool to improve consistency in cell cultureRegulatory news - February 2020Regulatory news - February 2020January news: Evolving UK cell and gene therapy clinical trial landscapeJanuary news: Evolving UK cell and gene therapy clinical trial landscapeDecember news: Optimising clinical adoption of advanced therapies in the UKDecember news: Optimising clinical adoption of advanced therapies in the UKNovember news: Accelerating cell and gene therapies towards commercialisationNovember news: Accelerating cell and gene therapies towards commercialisationSeptember news: Working with NHS and industry to accelerate adoption of advanced therapiesSeptember news: Working with NHS and industry to accelerate adoption of advanced therapiesAdvanced Therapies Apprenticeship Community roadshow showcases value of apprenticeships for upskilling in the advanced therapies industryAdvanced Therapies Apprenticeship Community roadshow showcases value of apprenticeships for upskilling in the advanced therapies industryRegulatory news - January 2020Regulatory news - January 2020Press release: New Cell and Gene Therapy Catapult CEO brings continuity and ambition for further impactPress release: New Cell and Gene Therapy Catapult CEO brings continuity and ambition for further impactSupporting progress of cell and gene therapy industrialisation with new aseptic manufacturing courseSupporting progress of cell and gene therapy industrialisation with new aseptic manufacturing course